Literature DB >> 26095383

Antibiotic Resistance and Virulence Potentials of Shiga Toxin-Producing Escherichia coli Isolates from Raw Meats of Slaughterhouses and Retail Markets in Korea.

Hyun-Jung Park1, Jang Won Yoon2, Eun-Jeong Heo1, Eun-Kyoung Ko3, Ki-Yeon Kim4, Young-Jo Kim1, Hyang-Jin Yoon3, Sung-Hwan Wee3, Yong Ho Park4, Jin San Moon3.   

Abstract

In this study, the prevalence of Shiga toxin-producing Escherichia coli (STEC) was investigated among raw meat or meat products from slaughterhouses and retail markets in South Korea, and their potential for antibiotic resistance and virulence was further analyzed. A total of 912 raw meats, including beef, pork, and chicken, were collected from 2008 to 2009. E. coli strains were frequently isolated in chicken meats (176/233, 75.9%), beef (102/217, 42.3%), and pork (109/235, 39.2%). Putative STEC isolates were further categorized, based on the presence or absence of the Shiga toxin (stx) genes, followed by standard O-serotyping. Polymerase chain reaction assays were used to detect the previously defined virulence genes in STEC, including Shiga toxins 1 and Shiga toxin 2 (stx1 and 2), enterohemolysin (ehxA), intimin (eaeA), STEC autoagglutination adhesion (saa), and subtilase cytotoxin (subAB). All carried both stx1 and eae genes, but none of them had the stx2, saa, or subAB genes. Six (50.0%) STEC isolates possessed the ehxA gene, which is known to be encoded by the 60-megadalton virulence plasmid. Our antibiogram profiling demonstrated that some STEC strains, particularly pork and chicken isolates, displayed a multiple drug-resistance phenotype. RPLA analysis revealed that all the stx1-positive STEC isolates produced Stx1 only at the undetectable level. Altogether, these results imply that the locus of enterocyte and effacement (LEE)-positive strains STEC are predominant among raw meats or meat products from slaughterhouses or retail markets in Korea.

Entities:  

Keywords:  Antibiogram; Retail meat; Shiga toxin; Stx-producing E. coli; polymerase chain reaction

Mesh:

Substances:

Year:  2015        PMID: 26095383     DOI: 10.4014/jmb.1502.02034

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  5 in total

1.  Virulence and extended-spectrum β-lactamase encoding genes in Escherichia coli recovered from chicken meat intended for hospitalized human consumption.

Authors:  Gamal A Younis; Rasha M Elkenany; Mohamed A Fouda; Noura F Mostafa
Journal:  Vet World       Date:  2017-10-28

2.  Pathogenic and phylogenetic characteristics of non-O157 Shiga toxin-producing Escherichia coli isolates from retail meats in South Korea.

Authors:  June Bong Lee; Dalmuri Han; Hyung Tae Lee; Seon Mi Wi; Jeong Hoon Park; Jung-Woo Jo; Young-Jae Cho; Tae-Wook Hahn; Sunjin Lee; Byunghak Kang; Hyo Sun Kwak; Jonghyun Kim; Jang Won Yoon
Journal:  J Vet Sci       Date:  2018-03-31       Impact factor: 1.672

3.  Isolation and molecular characterization of multidrug-resistant Escherichia coli from chicken meat.

Authors:  Md Masudur Rahman; Asmaul Husna; Hatem A Elshabrawy; Jahangir Alam; Nurjahan Yasmin Runa; A T M Badruzzaman; Nahid Arjuman Banu; Mohammad Al Mamun; Bashudeb Paul; Shobhan Das; Md Mahfujur Rahman; A T M Mahbub-E-Elahi; Ahmed S Khairalla; Hossam M Ashour
Journal:  Sci Rep       Date:  2020-12-15       Impact factor: 4.379

4.  Prevalence, virulence potential, and pulsed-field gel electrophoresis profiling of Shiga toxin-producing Escherichia coli strains from cattle.

Authors:  Hee-Jin Dong; Soomin Lee; Woohyun Kim; Jae-Uk An; Junhyung Kim; Danil Kim; Seongbeom Cho
Journal:  Gut Pathog       Date:  2017-04-21       Impact factor: 4.181

5.  Genomic Epidemiology of Shiga Toxin-Producing Escherichia coli Isolated from the Livestock-Food-Human Interface in South America.

Authors:  Nicolás Galarce; Fernando Sánchez; Beatriz Escobar; Lisette Lapierre; Javiera Cornejo; Raúl Alegría-Morán; Víctor Neira; Víctor Martínez; Timothy Johnson; Danny Fuentes-Castillo; Elder Sano; Nilton Lincopan
Journal:  Animals (Basel)       Date:  2021-06-22       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.